Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Pancreatic Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05642962
What this trial is testing

Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Metastatic Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic CancerMetastatic Pancreatic Adenocarcinoma+10 more
Memorial Sloan Kettering Cancer Center 17
Testing effectiveness (Phase 2)WithdrawnNCT03778879
What this trial is testing

Pre-operative Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma With or Without CCX872-B

Who this might be right for
Adenocarcinoma of the PancreasPancreas Cancer
Alan Katz
Early research (Phase 1)UnknownNCT02599662
What this trial is testing

Intraoperative Radiation Therapy for Resectable Pancreas Cancer

Who this might be right for
Pancreas Cancer
Loyola University 12
Testing effectiveness (Phase 2)Study completedNCT02959879
What this trial is testing

Neo-adjuvant FOLF(IRIN)OX for Resectable Pancreatic Adenocarcinoma

Who this might be right for
Resectable Pancreatic Duct Adenocarcinoma
University Hospital, Rouen 153
Post-approval studies (Phase 4)Study completedNCT02335151
What this trial is testing

CTC Pancreatic Adenocarcinoma

Who this might be right for
AdenocarcinomaCirculating Tumor CellsPancreatic Neoplasms
University of Zurich 86
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07616362
What this trial is testing

Personalize (Signature Driven) Neoadjuvant Chemotherapy Trial for Patients With Resectable Borderline Pancreatic Ductal Adenocarcinoma.

Who this might be right for
Borderline Resectable Pancreatic Ductal Adenocarcinoma
Federation Francophone de Cancerologie Digestive 110
Testing effectiveness (Phase 2)Ended earlyNCT01531712
What this trial is testing

Study of Neoadjuvant Treatment in Patients With Pancreatic Cancer That is Potentially Resectable

Who this might be right for
Pancreatic Cancer
Institut Català d'Oncologia 6
Not applicableStudy completedNCT05514171
What this trial is testing

Prospective Registry of Patients With Pancreas Adenocarcinoma Resectable and Borderline

Who this might be right for
Chemotherapy EffectPancreas Cancer
Hospital del Mar 300
Testing effectiveness (Phase 2)Ended earlyNCT01760252
What this trial is testing

Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma Protocol

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Beth Israel Medical Center 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT03483038
What this trial is testing

The Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
University of Florida 45
Not applicableActive Not RecruitingNCT04902352
What this trial is testing

The DISSECT Study: Effect of Peri-aDventItial SMA diSsECtion on Margin sTatus During Pancreaticoduodenectomy for Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
University Hospital Birmingham NHS Foundation Trust 102
Early research (Phase 1)Study completedNCT04106856
What this trial is testing

Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaLocally Advanced Unresectable Pancreatic Adenocarcinoma+4 more
University of Utah 22
Large-scale testing (Phase 3)UnknownNCT03251365
What this trial is testing

Intrabdominal Hyperthermic Chemotherapy and Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Adenocarcinoma
Hospital General de Ciudad Real 42
Testing effectiveness (Phase 2)Looking for participantsNCT06816914
What this trial is testing

Perioperative NALIRIFOX (liposomal Irinotecan in Combination with Fluorouracil, Leucovorin, and Oxaliplatin) in Resectable Pancreatic Adenocarcinoma: Randomized Phase II Trial

Who this might be right for
Resectable Pancreatic Adenocarcinoma
Taichung Veterans General Hospital 84
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940286
What this trial is testing

Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaResectable Pancreatic AdenocarcinomaStage IA Pancreatic Cancer AJCC v8+3 more
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Looking for participantsNCT05462496
What this trial is testing

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Icahn School of Medicine at Mount Sinai 25
Large-scale testing (Phase 3)WithdrawnNCT03649035
What this trial is testing

Eus-guided Cryothermal Ablation in Stage III Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaPancreatic CancerPancreas Neoplasm
Istituto Clinico Humanitas
Large-scale testing (Phase 3)Study completedNCT00003049
What this trial is testing

Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Mayo Clinic 100
Testing effectiveness (Phase 2)UnknownNCT02446093
What this trial is testing

Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma

Who this might be right for
Borderline Resectable Pancreatic Adenocarcinoma
Candel Therapeutics, Inc. 54
Next Page